- Coordinator
- Cephalgo, France
- Runs
- 1 November 2023 to 30 April 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €3.6m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190129251
What the project is doing
In the project's own words, from its summary on CORDIS.
150M people suffer from mental disorders in Europe & this number is sharply increasing. There are not enough psychiatrists to cope with the situation: a psychiatrist sees 1,000 patients in sessions separated every 3-4 months. Psychiatrists have no way to know if a patient's treatment is working and if there is any risk of relapse/suicide between sessions. A patient's emotional status gives insights into treatment effectiveness and diagnosis of major depressive disorder, but there are no accurate tools to monitor emotions remotely and continuously.
Cephalgo has solved this challenge & developed the first accurate, remote & continuous emotion tracker to monitor treatment effectiveness, and predict the best course of treatment for a given patient profile. Combining speech analysis & an AI-driven emotion recognition algorithm, our AI detects emotions with high accuracy & predicts the best treatment to reduce the trial & error approach currently employed in psychiatry.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Cephalgo | Strasbourg | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI